Two cases of "fulminant" type 1 diabetes suggesting involvement of autoimmunity

Ann N Y Acad Sci. 2003 Nov:1005:359-61. doi: 10.1196/annals.1288.059.

Abstract

Recently, a novel subtype of type 1 diabetes, so-called fulminant type 1 diabetes, has been proposed. One of the characteristics of this subtype is the absence of detectable "islet-associated" autoantibody, so it was originally proposed as being "nonautoimmune-mediated"; however, it has not yet been concluded whether autoimmunity is involved. We have previously shown that serum interferon-inducible protein-10 and glutamic acid decarboxylase-reactive CD4(+) interferon-gamma-producing cells in the peripheral blood are good markers for T cell-mediated autoimmunity in type 1 diabetes. Here, we report two cases of fulminant type 1 diabetes in which these markers were detected and in which the involvement of islet-associated autoimmunity is suggested.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Autoantibodies / blood
  • Autoimmunity*
  • Chemokine CXCL10 / blood
  • Diabetes Mellitus, Type 1 / immunology*
  • Diabetes Mellitus, Type 1 / physiopathology
  • Glutamate Decarboxylase / immunology
  • Humans
  • Isoenzymes / immunology
  • Male
  • Middle Aged
  • T-Lymphocytes / immunology

Substances

  • Autoantibodies
  • Chemokine CXCL10
  • Isoenzymes
  • Glutamate Decarboxylase
  • glutamate decarboxylase 2